Skip to content
Company Terminals Nifty 50 Company TerminalsNifty 500 Index TerminalRecently Listed IPOs Markets Bhav Dhan Index: fear and greed, decodedFII DII data today, decodedNifty P/E, measured five waysMorning Open: before the bellEvening Close: the day, readThis season's results, read forensicallyAlerts by email and TelegramMarket Movers: why stocks moved IPO Intel Live and upcoming IPOsRecently listed: score vs outcomeSME IPO forensics Research Research and analysisIndustry research Calculators All calculatorsGold desk Services Roadmap Pricing Get started →
The $13 Billion Machine: Inside the Macro-Economics of the 2026 FIFA World CupAlibaba share price is up 16% today. what next for Baba stock?IPO Allotment status check online by PAN number 2025UnitedHealth (UNH Stock): You should stay away from itQ4 results live updates: Adani Group companies in focusThe $13 Billion Machine: Inside the Macro-Economics of the 2026 FIFA World CupAlibaba share price is up 16% today. what next for Baba stock?IPO Allotment status check online by PAN number 2025UnitedHealth (UNH Stock): You should stay away from itQ4 results live updates: Adani Group companies in focus
July to September 2024 · consolidated

Dabur India Ltd. Q2 FY25 results

DABUR · Fast Moving Consumer Goods

Open the terminal
✓Clean on 7 checks7 of 19 checks ran · from the quarterly statements; filing read not yet in
Revenue₹3,029 cr▼ 5.5%on the year▼ 9.6%on the quarter
EBITDA₹553 cr▼ 16.3%on the yearmargin 18.3% (−237 bps)
Net profit₹418 cr▼ 17.6%on the year▼ 15.4%on the quarter
EPS₹2.40▼ 17.5%on the year

What changed

  1. Revenue ₹3,029 cr, −5.5% on the year; EBITDA margin 18.3%, −237 bps.
  2. Part of the profit growth came from outside the business: reported −17.6%, core −26.2%. Other income, exceptional items or tax added 9 points.
  3. Every check that could run (7 of 19) came back quiet.

The quarter, explainedfrom the quarterly statements

Dabur India Ltd. reported revenue of ₹3,029 cr for July to September 2024, −5.5% on the year and −9.6% on the quarter.

Operating profit (EBITDA) was ₹553 cr, a margin of 18.3%, −237 bps on the year and −130 bps on the quarter. Over the last 6 quarters the margin has ranged from 16.6% to 20.6%, averaging 19.1%. Operating costs grew −2.6%, faster than revenue at −5.5%, so operating profit grew less than sales.

Net profit was ₹418 cr, −17.6% on the year and −15.4% on the quarter, with earnings per share of ₹2.40. Profit before other income, one-offs and tax fell 26.2%, so 9 points of the headline growth came from outside the core business. The tax rate of 24% is in line with its recent average.

Pharma quarters swing with US generic launches and price erosion, while India formulations grow more steadily. Currency gains and other income can be material, so headline profit needs a check against operating profit. The quarterly statements do not carry the US and India split, R&D spend and any FDA observations; those come with the filing read.

On earnings per share of ₹10.09 over the last four quarters, the stock at ₹375.25 trades at 37.2 times trailing earnings.

Written from the quarterly statements. The filing read adds the balance sheet and cash flow filed with this quarter, the auditor's review, segment results, one-off items line by line and what management said on the call.

Questions to ask: none this quartereach one with its numbers and source

No check fired. That is a statement about the checks below, not a verdict on the company.

Also worth knowing

iNote

Operating margin slipped on the year.

EBITDA margin 18.3%, −237 bps on the year (−130 bps on the quarter).

Source: Quarterly statements

Could not run on this quarter: Exceptional items that recur, Cash behind the profit, Receivables against sales, Inventory against sales, Borrowing while holding cash, Auditor's review or audit report, IPO money used as stated, Related-party transactions, Exits, postponements, restatements, Promoter pledges and allotments, Earlier promises against delivery, When the results were filed. Most need the filing read (balance sheet, cash flow, auditor, disclosures).

Where the profit change came fromSep '23 → Sep '24

₹507 crSep'23−₹108 crBusiness(EBITDA)−₹13.0 crDepreciation−₹19.0 crFinancecost+₹35.0 crOtherincome+₹12.2 crTax+₹3.8 crOtherlines₹418 crSep'24Scale starts at ₹283 cr, not zero, so the changes are visible

Net profit a year ago, each driver's change, and net profit now. Blue added profit, red took it away.

The half year: balance sheet and cashfiled with Q2

This quarter's filing carries a balance sheet and a cash flow statement. The cash, receivables and borrowing checks run once the filing read is in.

Every quartersame rules, every quarter

Q3 FY24Q4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Q3 FY26Q4 FY26Q1 FY27Q2 FY27
Revenue₹3,255 cr₹2,815 cr₹3,349 cr₹3,029 cr₹3,355 cr₹2,830 cr₹3,405 cr₹3,191 cr₹3,559 cr₹3,038 cr₹3,764 cr₹3,563 cr
YoY——+7%−5%+3%+1%+2%+5%+6%+7%+11%+12%
EBITDA margin20.5%16.6%19.6%18.3%20.3%15.1%19.6%18.4%20.6%15.2%19.7%17.7%
Other income, % of PBT19%28%20%28%20%34%22%24%18%37%23%27%
Exceptional items————————————
Tax rate23%25%23%24%22%24%23%22%22%24%22%23%
Net profit₹506 cr₹341 cr₹494 cr₹418 cr₹516 cr₹313 cr₹508 cr₹445 cr₹554 cr₹362 cr₹586 cr₹499 cr
YoY——+8%−18%+2%−8%+3%+6%+7%+16%+15%+12%
Core profit YoY——+6%−26%−1%−16%+1%+10%+11%+10%+12%+9%
EPS₹2.90₹1.97₹2.82₹2.40₹2.95₹1.81₹2.90₹2.55₹3.16₹2.08₹3.33₹2.85
Flags··✓✓✓✓✓✓✓✓✓✓

Each quarter is read with the same rules. Balance-sheet and cash checks run on half-year and annual quarters; filing-read checks run where a read exists.

Alerts for Dabur India Ltd.Only when its results land or a check fires. No more than three a day; a digest for the rest. One click to stop.

Questions people ask

What were Dabur India Ltd. Q2 FY25 results?

Dabur India Ltd. reported revenue of ₹3,029 cr (−5.5% on the year) and net profit of ₹418 cr (−17.6% on the year) for July to September 2024.

Was Dabur India Ltd. profit growth driven by the core business?

Profit before other income, exceptional items and tax moved −26.2% on the year, against −17.6% for reported profit.

Are there any red flags in Dabur India Ltd. Q2 FY25 results?

None of the 7 checks that could run raised a question.

Is this a recommendation?

No. FinMinutes reports what was filed and the questions the numbers raise. It does not recommend buying, selling or holding any security.

Numbers as filed with the exchanges, read by rules. Every flag is a question with its source, not an accusation. FinMinutes is a financial data and analytics platform; nothing here is a recommendation to buy, sell or hold any security. How each check works.

Chat on WhatsApp